Janka Lincoln, M.D.

Professional Background

Jana Lincoln, M.D. is a board-certified psychiatrist. She specializes in the assessment and treatment of patients with severe mental illness who are hospitalized in the civilian hospital as well as in the forensic unit of the state hospital. Additionally, she performs electroconvulsive treatment (ECT). Dr. Lincoln is Director of Clinical Services and Associate Program Director for the Residency program. Dr. Lincoln graduated from Comenius University - Jessenius Faculty of Medicine in the Slovak Republic and completed her residency in psychiatry at the KU School of Medicine in Wichita. She has additional training in ECT from Duke University and training in Principles of Medical Education from Harvard University.

• MD, General Medicine, Comenius Univ, Jessenius, Martin, Slovakia
• Residency, Psychiatry, University of Kansas School of Medicine-Wichita, Wichita, KS
• Other, Clinical Education, Harvard School of Medicine, Boston, Massachusetts
• Other, Electroconvulsive Treatment (ECT), Duke University Medical Center, Durham, North Carolina

• Kansas Board of Healing Arts Medical License, Kansas Board of Healing Arts
• National Plan and Provider Enumeration System NPPES, National Plan and Provider Enumeration System

• Kansas Psychiatric Society, Area Representative, 2022 - Present
• Kansas Psychiatric Society, American Psychiatric Association Area 4 Representative, 2020 - 2022
• American Psychiatric Association, Distinguished Fellow, 2018 - Present
• Ascension - Via Christi Wichita, Pharmacy and Therapeutics, Member, 2015 - Present
• Ascension - Via Christi Wichita, Peer Review, Member, 2013 - Present
• Ascension - Via Christi Wichita, Project Mayflower, Member, 2013 - 2014
• Ascension - Via Christi Wichita, Director, 2013 - 2017

---

• Kalu, Walter, Lincoln, Jana, Troutman, Megan. 2018. Case Presentation: Lithium-Haloperidol Induced Neurotoxicity and Catatonia in Patient With Bipolar Mania With Psychosis: Diagnosis and Treatment. http://www.psychcongress.com/posters/case-presentation-lithium-haloperidol-induced-neurotoxicity-and-catatonia-patient-bipolar
• Flynn, A, Lincoln, J, Burke, M. 2016. Homicidality and Psychosis Caused by an Over-the-Counter Performance-Enhancing Supplement Containing Dendrobium Extract and L-Dopa.. P & T : a peer-reviewed journal for formulary management, 41 (6), 381-4
• Lincoln, Jana, Wehler, Cheryl. 2013. Out of Pipeline - Vortioxetine for Major Depressive Disorder. Current Psychiatry, 13 (2), 67-70
• Lincoln, Jana, Tripathi, Aveekshit. 2011. Out of Pipeline – Lurasidone for Schizophrenia. Current Psychiatry, 10 (1), 67-70
• Lincoln, J, Stewart, M., E, Preskorn, S., H. 2010. How sequential studies inform drug development: evaluating the effect of food intake on optimal bioavailability of ziprasidone.. Journal of psychiatric practice, 16 (2), 103-14
• Lincoln, Jana, Preskorn, Sheldon., H. 2009. Out of Pipeline – Asenapine. Current Psychiatry, 8 (12), 75-85
• Lincoln, Jana, Preskorn, Sheldon., H. 2008. Desvenlafaxine for Depression. The Journal of Family Practice, 17 (6)
• Burke, M., J, Lincoln, J. 2006. Aripiprazole and haloperidol: a clinically relevant interaction with a dopamine antagonist and partial agonist.. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 18 (2), 129-30
• Burke, Michael., J, Lincoln, Jana, Rakel, R., E, Bope, E. 2006. Mood Disorders, 2006